- ChiroRab™ has an excellent safety and tolerability profile. Safety of ChiroRab™ has been established in more than 20 clinical trials worldwide in both children, adults and post-marketing reports.
- In clinical trials, ChiroRab™ has been associated with local reactions, such as injection site pain (30–85%) and induration (15–35%).
- Most of the side-effects in clinical studies were minor, self-limiting and required no treatment.
Safety of ChiroRab™
